Jen joins our Cancer Biology Team as an Associate Principal Scientist, with drug discovery experience in targeted protein degradation, MAPK signalling and chaperone biology. Jen has worked in both biotech and academic settings including PhoreMost Ltd., Vanderbilt University, and the Institute of Cancer Research.
